Takeaways from RPA 2026: Practical Challenges in Navigating Increasing Complexity

Differentiation Is Now the Starting Point

Differentiation is no longer something we layer on top of a narrative—it’s the foundation. With more therapies entering the space, clinicians are trying to understand how each one fits. The question we need to answer is “why this therapy for this patient?” That requires a sharper focus on mechanism, clinical relevance, and positioning.

Precision Medicine Must Be Actionable

An emphasis on genetics and patient segmentation reflects a broader shift toward more targeted approaches to care, and clinicians are focused on how to operationalize this. There is interest in precision medicine, but it needs to translate into clear guidance: who to treat, how to identify them, and what to do next. The impact of precision medicine will depend on how clearly it can be translated into actionable clinical decision-making.

Early Intervention Is Not Yet Standard Practice

While there is increasing discussion around earlier treatment and disease modification, the field remains largely focused on late-stage care, particularly dialysis and transplantation. This creates a disconnect between where innovation is heading and how care is currently delivered, and represents an opportunity to shift the narrative. Positioning therapies around disease trajectory and earlier intervention can help change how clinicians think about timing and impact.

Data Usability Is Now the Core Challenge

A recurring theme was the sheer volume of data clinicians are managing, and the need to interpret and apply it efficiently. This creates a new kind of bottleneck, where decision-making is limited by time and cognitive load. Clarity, prioritization, and structure are increasingly important to help clinicians navigate this environment.

Access and Real-World Constraints Are Driving Behavior

Discussions around payer dynamics, prior authorization, and value-based care reflected the reality clinicians are dealing with every day. Even highly effective therapies may not be viable if they are difficult to access or implement. Clinical value is critical, but it must be framed within the context of access, cost, and workflow. Adoption is increasingly shaped by what is practical.

Decision-Making Is Becoming More System-Driven

The continued focus on practice consolidation and integrated care models highlights a shift away from purely individual decision-making. Physicians are increasingly operating within systems where treatment choices are influenced by broader organizational and financial considerations. We are no longer speaking only to individual clinicians; we are supporting decisions that involve multiple stakeholders.

AI and Workflow Discussions Reflect a Need for Efficiency

Artificial intelligence (AI) and digital tools were prominent topics, but the underlying driver was consistent: improving efficiency. These conversations were grounded in real challenges, including workflow fragmentation, administrative burden, and limited time with patients. Whether digital or therapeutic, solutions are being evaluated not just on performance, but on how well they fit into existing workflows and reduce overall burden.

Looking Ahead

In sum, the key takeaway is that nephrology is becoming more complex, but also more practical in its expectations. Clinicians are managing increasing amounts of information within constrained systems, and decision-making is shaped as much by feasibility as by clinical evidence.

Going forward, the emphasis will likely continue to shift toward treatment approaches that simplify decision-making, elucidate positioning, and align with real-world practice. With both options and pressures increasing, success will lie in the ability to efficiently navigate complexity.